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Abstract
Copy number polymorphism (CNP) is ubiquitous in eukaryotic genomes, but the degree to which this reflects the action of
positive selection is poorly understood. The first gene in the Plasmodium folate biosynthesis pathway, GTP-cyclohydrolase I
(gch1), shows extensive CNP. We provide compelling evidence that gch1 CNP is an adaptive consequence of selection by
antifolate drugs, which target enzymes downstream in this pathway. (1) We compared gch1 CNP in parasites from Thailand
(strong historical antifolate selection) with those from neighboring Laos (weak antifolate selection). Two percent of
chromosomes had amplified copy number in Laos, while 72% carried multiple (2–11) copies in Thailand, and differentiation
exceeded that observed at 73 synonymous SNPs. (2) We found five amplicon types containing one to greater than six genes
and spanning 1 to .11 kb, consistent with parallel evolution and strong selection for this gene amplification. gch1 was the
only gene occurring in all amplicons suggesting that this locus is the target of selection. (3) We observed reduced
microsatellite variation and increased linkage disequilibrium (LD) in a 900-kb region flanking gch1 in parasites from Thailand,
consistent with rapid recent spread of chromosomes carrying multiple copies of gch1. (4) We found that parasites bearing
dhfr-164L, which causes high-level resistance to antifolate drugs, carry significantly (p=0.00003) higher copy numbers of
gch1 than parasites bearing 164I, indicating functional association between genes located on different chromosomes but
linked in the same biochemical pathway. These results demonstrate that CNP at gch1 is adaptive and the associations with
dhfr-164L strongly suggest a compensatory function. More generally, these data demonstrate how selection affects multiple
enzymes in a single biochemical pathway, and suggest that investigation of structural variation may provide a fast-track to
locating genes underlying adaptation.
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Introduction
A spate of studies over the past five years have described
widespread copy number variation (CNP) within the genomes of
humans, mice, Drosophila and other eukaryotes [1–5]. The existence
of large regions of the genome that vary in copy number between
individuals has lead to a reconsideration of the importance of
structural variationforourunderstandingofgeneticandphenotypic
variation [6]. However, it is unclear whether CNP evolution is
predominantly neutral, or whether positive or negative selection
play significant roles in shaping the patterns observed [1]. The fact
that CNPs tend to be enriched for particular gene classes, and for
genes showing evidence for positive selection at the nucleotide level,
strongly suggests the action of positive selection [7], although the
alternative explanation of purifying selection against CNP in
particular gene classes cannot be discounted. Furthermore, that
CNPs explain ,20% of variance in transcript abundance in
humans suggests that they have the potential to make a significant
contribution to disease susceptibility and adaptive evolution [8].
However, despite these indirect lines of evidence for positive
selection, adaptive copy number evolution has been demonstrated
or hypothesized in only a few cases. In humans there are two
notable examples. Gonzales et al [9] showed that protection from
HIV is associated with CNP at the CCL3L1 gene. This CNP shows
extreme geographical variation which further supports the action of
selection by HIV (or, more likely, by an older human pathogen)
[10]. Similarly, Perry et al [11] showed higher copy number of the
amylase gene in populations with high starch diets.
CNP is also widespread in the malaria parasite genome [12,13].
Malaria parasites are exposed to strong selection from the human
immuneresponseandtreatmentwithantimalarialdrugs.Theyhave
relatively small genomes (23 Mb) and haploid genetics, and can be
grown and genetically manipulated in the laboratory, so provide a
useful eukaryotic organism for investigating the functional role of
CNP. One CNP on chromosome (chr.) 5 is known to underlie a
multidrug resistance phenotype: chromosomes carrying this CNP
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manipulationof copy numberaltersresponse to multiple drugs [16].
However, this one example of adaptive copy number variation in P.
falciparum has been regarded as an exceptional case, and SNP based
approaches have been prioritized as the primary tool for mapping
functional genes in Plasmodium [17].
The first cGH study of P. falciparum in 16 laboratory isolates
revealed a particularly interesting CNP containing GTP-cyclohy-
drolase I (gch1) [12]. This gene encodes the first and rate limiting
enzyme in the folate metabolism pathway (Figure 1) [18,19]. Two
key enzymes in later stages of this pathway–dihydrofolate
reductase (dhfr) (chr. 4) and dihydropteroate synthase (dhps) (chr.
8)–are targets of the antifolate drugs pyrimethamine and
sulfadoxine, which are combined in the drug Fansidar (Roche).
This drug replaced chloroquine as the first-line treatment against
malaria in many countries, but resistance has spread rapidly where
it has been deployed. Specific point mutations (N51I, C59R,
S108N, I164L) in parasite dhfr alter the binding of pyrimethamine
to the enzyme’s active site [20]. In addition to causing resistance,
mutations in dhfr reduce enzyme efficacy and carry adverse fitness
effects [21,22, but see 23]. Similarly, mutations in dhps (S436A/F,
A437G, K540E, A581G, and A613T/S) underlie resistance to
sulfadoxine [20]. Kidgell et al [12] speculated that increased gene
dosage might play a compensatory role in antifolate resistance by
increasing flux in the pathway to compensate for reduced efficacy
of dhfr and/or dhps genes bearing resistance mutations.
This study was designed to determine whether CNP at gch1 is a
consequence of adaptive evolution. To do this, we examined the
population genetics of gch1 CNP in Laos and Thailand. These two
neighboring countries in SE Asia have contrasting selection
histories with antifolate drugs. In Western Thailand antifolate
drugs were the first line treatment from 1970–80, and resistance
mutations at both dhps and dhfr are fixed or at high frequency
[24,25]. By contrast, in Laos antifolate drugs were the second line
drug until 2006, but were seldom used [26], and resistance
mutations are at lower frequencies in both dhfr and dhps [25,27].
We provide compelling evidence–from patterns of population
differentiation, hitchhiking, and amplicon structure–that the gch1
CNP (chr. 12) in P. falciparum results from recent adaptive
evolution that is most likely associated with antifolate treatment.
Furthermore, we show strong association between gch1 CNP and a
critical mutation in dhfr, indicating functional linkage between
genes on different chromosomes in the same biochemical pathway.
Materials and Methods
Sample Collection
We collected 5 mL blood samples from P. falciparum infected
patients visiting the malaria clinic at Mawker-Thai on the Thai-
Burma border between December 2000 and September 2003.
These patients had not visited the malaria clinic within the past 60
days, and had no history of prior malaria treatment during this
time. The clinic serves people on both sides of the border; 90% of
patients travel from within a 10 km radius around the clinic
(Franc ¸ois Nosten, personal communication). We collected samples
from Phalanxay (Savannaket) in Laos between June 2002 and Sept
2003 from patients involved in clinical drug efficacy trials.
Collection protocols were approved by the Ethical Committee of
the Faculty of Tropical Medicine, Mahidol University, Bangkok,
and by the Institutional Review Board at the University of Texas
Health Science Center at San Antonio. Parasite DNA was
prepared by phenol/chloroform extraction of whole blood,
following removal of buffy coats as described previously [28].
Plasmodium Genetics and Biology
Malaria parasites are obligately sexual protozoans. Haploid
blood-stage parasites replicate asexually within the human host
Figure 1. The folate biosynthesis pathway of P. falciparum. The
steps catalyzed by gch1, dhfr and dhps are highlighted. The positions at
which antifolate drugs (Pyrimethamine (PYR) and Sulfadoxine (SDX))
target the pathway are marked. Abbreviations: pyruvoyltetrahydrop-
terin synthase (ptps), hydroxymethyldihydropterin pyrophosphokinase
(pppk), dihydrofolate synthase (dhfs). Modified from [18].
doi:10.1371/journal.pgen.1000243.g001
Author Summary
Recent comparative genomic hybridization studies have
revealed extensive copy number variation in eukaryotic
genomes. The first gene in the Plasmodium folate
biosynthesis pathway, GTP-cyclohydrolase I (gch1), shows
extensive copy number polymorphism (CNP). We provide
compelling evidence that gch1 CNP is adaptive and most
likely results from selection by antifolate drugs, which
target enzymes downstream in this pathway. Gch1 CNP
shows extreme geographical differentiation; hitchhiking
reduces diversity and increases LD in flanking sequence,
indicating recent rapid spread within Thailand, while
amplicon structure reveals multiple origins and parallel
evolution. Furthermore, strong association between ele-
vated copy number and a critical mutation dhfr-I164L that
underlies high-level antifolate resistance indicates func-
tional linkage and fitness epistasis between genes on
different chromosomes. These data reveal hidden com-
plexity in the evolutionary response to antifolate treat-
ment and demonstrate that analysis of structural variation
can provide a fast-track to locating genes that underlie
adaptation.
Adaptive Copy Number Evolution in Plasmodium
PLoS Genetics | www.plosgenetics.org 2 October 2008 | Volume 4 | Issue 10 | e1000243and differentiate into male and female gametocytes. Male and
female gametes fuse in the mosquito midgut generating a short
lived diploid stage (ookinete). Meiosis then gives rise to haploid
infective stages (sporozoites) that are transmitted to humans during
mosquito feeding. Self-fertilization predominates in regions of low
transmission such as Thailand and Laos, because most infected
humans, and therefore mosquito blood meals, contain a single
parasite clone. The recombination rate is high (1 cM=17 kb), but
the effective recombination rate is modified by the rate of selfing in
natural parasite populations. The effective rate of recombination (r9)
is given by r9=r(1-F) where r is the recombination rate and F is the
inbreeding coefficient [29,30]. In Thailand the inbreeding
coefficient is estimated to be between 0.6–0.9 [31]. The generation
time (from mosquito to mosquito) is variable, but is estimated to be
,8 weeks [31].
Microsatellite Genotyping
We used microsatellite genotyping to identify infections
containing .1 parasite clone. We genotyped seven di- or tri-
nucleotide markers distributed on different chromosomes: ARA2
(chr. 11), POLYa (chr. 4), TA1 (chr. 6), C2M1 (chr. 2), C3M54
(chr. 3), TA60 (chr. 13), and C4M30 (chr. 4). Primers and
protocols for amplifying these loci are described in [32]. We
amplified microsatellites using fluorescent end-labeled oligos, ran
products on an ABI 3100 capillary sequencer, and scored alleles
using GENESCAN and GENOTYPER software. Multiple clone
infections were defined as those in which one or more of the seven
loci showed multiple alleles. Minor alleles were scored if they were
.33% the height of predominant alleles [33].
We genotyped 33 dinucleotide microsatellites on chr. 12
flanking gch1 to examine expected heterozygosity and LD. These
included 10 markers situated within a 14 kb window containing
gch1. Oligos and locus details are listed in Table S1. These were
genotyped using the methods described above. However, for 17/
33 loci we used the M13 tailing method [34] in which the
fluorescent labeled M13 oligo (tgtaaaacgacggccagt) was added to
the 59 of the forward oligo to label PCR products.
Measurement of gch1 Copy Number and
Characterization of Amplicons
We used a real-time PCR assay to measure copy number of gch1
relative to single copy gene (PFL0770w: Seryl-T synthetase). Assay
details are provided in Table S2. We measured amounts of gch1 or
Seryl-T synthetase PCR products using Minor Groove Binding
(MGB) probes (Applied Biosystems, Foster City, CA). We used the
DDCT method to measure copy number relative to a standard
calibrator sample. We initially used the sequenced parasite strain
3D7 as the calibrator. However, initial trials indicated that this
parasite line has multiple copies of gch1, as observed previously [12].
We therefore measured gene copy number relative to a field sample
with a single copy of gch1. All assays were run in quadruplicate in
10 ml volumes on 384-well plates on an ABI 7900HT real-time
PCR machine. We excluded real-time PCR data when the CT was
.32 for either test or reference gene, or if the upper 95%
confidence interval around the copy number estimate is .0.4, or if
the estimated copy number was ,0.5. For some analyses the
continuous real-time estimates were made discrete, by rounding to
the nearest integer value. To ensure data comparability we run real-
time assays for samples from Thailand and Laos on the same 384-
well plates and included parasite 3D7 (which had 4.560.36 (1 s.d.)
copies in 8 replicate assays) as a positive control on each plate.
We also used real time assays for genes flanking gch1 on chr. 12
to identify the size and gene content amplified chromosomal
regions (table S2) while we amplified and sequenced breakpoint
specific PCR products (table S3) to identify the precise position of
the chromosomal breakage points (Figure S1) using methods
previously described [14].
Gch1 Sequencing
We sequenced gch1 from 24 parasites with a single copy of gch1
from Laos and from 24 parasites from Thailand (8 with single
copies and 16 with multiple copies). 1205 bp sequences were PCR
amplified using the oligos TTCATTTAATGGACTGGAAA and
GGCTAATTTAAATTTTCCAC. Amplified products were se-
quenced directly on both strands using the BigDye Terminator
v3.1 cycle sequencing kit (Applied Biosystems, Inc., Foster City,
CA) and internal oligos CATTACTTTTATTTCCTTCC,
CATCTTTTACCTTTTGAAGG, GAACAAATAGAAGATAT-
GCTG, and CTTCAAAAGGTAAAAGATGG. BigDye products
were cleaned using Sephadex G-50 (Sigma-Aldrich Co., St. Louis,
MO) prior to sequencing.
SNP Genotyping
Weused primer extension to determine point mutations in dhfrand
dhps associated with antifolate resistance in P. falciparum using
protocols described previously [28]. Genotyping was performed by
primer extension using the ABI PRISM SNaPshot Multiplex Kit
(Applied Biosystems) and the products of the SNaPshot reactions
were scored on an ABI 3100 capillary sequencer using GENESCAN
and GENOTYPER software. This method allows simultaneous
genotyping of all five mutations in dhfr or dhps in single reactions [28].
We used the Illumina BeadXpress platform to genotype 96
synonymous SNPs. Targeted SNPs were chosen using the query
system in www.plasmodb.org. We searched for synonymous sites that
were polymorphic in the genome sequence data from laboratory
parasites Dd2, FCC-2, FCB, K1, VI/S. These were selected from
genes showing low levels of variation and dN/dS ratios ,1. We also
excluded surface expressed genes and transporters from our searches,
as well as genes in telomeric regions (100 kb from chromosome ends)
because these are enriched for antigenic loci. Only SNPs that were
deemed designable by Illumina (with SNP scores.0.4) were included
(table S4). Genotyping was carried out according to the Illumina
BeadXpress instructions, except we used 25 ng DNA rather than
250 ng starting DNA. We included parasites FCC-2, FCB, K1, VI/S
as controls. Two SNPs were not scoreable, while 4 others gave high
levels (.5%) of missing data. Five loci were monomorphic in the
controlssuggesting that they resultfrom errors in the existing genome
sequence data. Of the remaining 85 loci, 74 (87%) were polymorphic
in at least one sample, while 73 had minor allele frequencies .1% in
at least one of the two populations examined.
Parasite Culture and Expression Analysis
We compared gch1 gene expression in 6 parasite isolates that
varied in gch1copy number, to determine if expression is a reflection
of gene dosage. Parasites were cultured at 90% N2,5 %C o 2 5% O2
in complete media containing albumax, synchronized using
sorbitol, and aliquots were preserved in TriReagent (Molecular
Research Center Inc.) for RNA extraction. We treated samples with
DNase 1(Invitrogen) to ensure no genomic DNA was present and
confirmed absence of DNA by PCR. mRNA was transcribed using
RNA PCR core kit (Applied Biosystems), to generate cDNA. We
quantified levels of cDNA with the Taqman assay run on the ABI
PRISM 7900 using the oligos listed in Table S2.
Statistical Analysis
We used t-tests and Mann-Whitney U-tests to investigate
association between SNPs and CNP at gch1. Copy number was log
Adaptive Copy Number Evolution in Plasmodium
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heterozygosity (He) at each locus using the formula He=[n/
(n21)][12Spi
2], where n is the number of infections sampled and
pi is the frequency of the ith allele. For haploid blood stage malaria
parasites this statistic measures the probability of drawing two
different alleles from a population. The sampling variance of He





modification of the standard diploid variance [35]]. To examine
patterns of LD surrounding gch1 we measured Extended
Haplotype Homozygosity (EHH) [36] where EHH at a distance
x from the gene of interest is defined as the probability that two
randomly chosen haplotypes are homozygous for all microsatellites
in this region. These statistics (61 SD) were measured using the
EHH Calculator [37]. We calculated FST following [38] using
FSTAT2.9.3 [39].
Results/Discussion
Extensive CNP at gch1 in Thailand
Initially, we sampled P. falciparum from infected patients visiting
a single clinic on the Thailand-Burma border. Following removal
of multiple clone infections 140 samples were available. We found
between 1 and 11 copies of gch1 by taqman PCR with 72% of
parasites sampled carrying .1 copy. To determine the arrange-
ment and size of these genome amplifications we measured copy
number in genes surrounding gch1 (Figure 2a) and designed PCR
assays to identify chromosome breakpoints [14] (Table S3, Figure
S1). We found 5 different amplicon types containing one to .six
genes (Figure 2b). Breakpoint specific PCR assays indicate that
these were arranged in tandem. However we note that duplicative
transposition of some amplicons would not be detectable using this
assay. The most common of these amplicons contained only gch1
and accounted for 48% of all amplicon types, while the largest
amplicon (.11 kb), was found in only one sample. We sequenced
the chromosome breakpoints for 4 of the 5 amplicons. In each case
breakpoints were found in between genes in microsatellite
sequences or monomeric tracts (Figure S1). The amplicon size
data provides a natural mapping experiment. Gch1 was the only
gene observed in all amplicons. Hence, if CNP results from
selection, then gch1 is clearly the gene that is targeted.
Gch1 CNP Shows Extreme Geographical Variation
Comparing patterns of geographical differentiation in neutral
and putatively selected loci provides a powerful approach to
identify loci that underlie adaptation [25,40,41]. This approach is
based on the premise that allele distribution at neutrally evolving
loci will be determined by mutation and drift alone, while selection
will influence patterns observed at loci involved in adaptation. We
measured gch1 copy number in parasites from Phalanxay
(Southern Laos) for comparison with Thailand. These neighboring
countries differ considerably in history of antifolate treatment
[25,27]. In Thailand, there was intensive selection with antifolates
from 1970–1980 [42], whereas in Laos antifolates were the official
second line treatment for malaria until 2006, but in reality they
were very seldom used [26]. Differences in treatment policies and
antifolate selection are evident from patterns of polymorphism at
dhfr and dhps. All parasite samples (n=139) examined from
Thailand carried between 2 and 4 mutations at dhfr, and 80% of
parasite isolates carried the dhfr-164L mutation, while at dhps all
Thai parasites carried 2 or 3 mutations conferring resistance
(Figure 3, Table S5). In contrast, in Laos the dhfr-164L mutation
was absent, and 23% of parasites carried wild type dhfr alleles,
while 92% of parasites carried wild-type alleles at dhps (Figure 3,
Table S5).
While 72% of Thai parasites carry .1 copy of gch1, in Laos we
found just 2/122 (1.6%) parasites with .1 gch1 copy (Figure 3a).
Hence, there is strong differentiation (FST=0.67 [grouping
chromosomes with single or multiple copies of gch1]) between
parasites sampled ,500 km apart. The real-time copy number
data is supported by PCR assays of chromosome breakpoints for 4
of the 5 amplicon types (Table S3). Using these assays, we detected
tandem repeats in 72% of Thai samples, but in only 1% of samples
from Laos. One of the two parasites from Laos with .1 copy of
Figure 2. Structure and gene content of gch1 amplicons. The
span of each amplicon was established by real-time PCR and breakpoint
specific PCR assays. (a) Real-time PCR estimates of relative copy number
plotted for 9 genes including gch1 on chr. 12. The error bars show 95%
confidence intervals around the copy number estimate. The three plots
show the profiles observed for the 2.3 kb (top), 7.3 kb (middle) and
8.7 kb (bottom) amplicons. The location of gch1 is marked by a red bar
(b) Plot showing the span of the 5 amplicons types. The abundance of
each of the amplicon types in the Thai sample is shown in white on the
bars. The gene content in this region of the chr. 12 are shown beneath
the graph: all breakpoints were between genes. The 59 boundary for the
.11 kb amplicon fell outside the range of our real-time PCR assays and
was not defined: the bar shows the minimum size estimate for this
amplicon.
doi:10.1371/journal.pgen.1000243.g002
Adaptive Copy Number Evolution in Plasmodium
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amplicon real time PCR profile (Figure 2). To compare
differentiation at this gch1 CNP with neutral expectations, we
genotyped 96 synonymous SNPs (sSNPs) situated on all 14
chromosomes (Table S4) in the same population samples. These
sSNPs were located in genes with dN/dS ratios ,1 and were
polymorphic in genome sequence data from SE Asian parasites
[43,44]. The gch1 CNP shows greater differentiation than all 73
polymorphic sSNPs (defined as those loci with .1% frequency of
the minor allele in at least one population) consistent with strong
Figure 3. Geographical differentiation of the gch1 CNP. The frequency of chromosomes carrying different gch1 copy number is plotted in
Thailand (a) and Laos (b). (c) Map showing sampling locations in Thailand and Laos. The pie charts show the representation of alleles present at
known genes involved in antifolate resistance, and provides a molecular indicator of the strength of antifolate selection on these two populations.
White-wild type, yellow-1 mutation, orange-2 mutations, red-3 mutations, black-4 mutations. See table S5 for details of the alleles present. (d) The
distribution of FST for gch1 CNP and for 73 polymorphic sSNPs. The markers are plotted by position across the genome. The mean FST for sSNPs is
marked by the dotted line.
doi:10.1371/journal.pgen.1000243.g003
Adaptive Copy Number Evolution in Plasmodium
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FST at SNPs and CNPs because both the rate and the directionality
of mutation are likely to be radically different. However, we
suggest that comparing SNPs with CNP will provide a conserva-
tive test, because copy number mutations typically occur at higher
rates than SNPs [45] and may show frequent reversions to the
single copy state. Hence, homoplasy is expected to reduce
geographical differentiation at CNPs. The geographical distribu-
tion of gch1 CNP is suggestive of strong local adaptation, but on its
own does not constitute proof. Furthermore, the high frequency of
gch1 CNP in Thailand is consistent with the hypothesis that
amplification is driven by antifolate treatment.
Hitchhiking Demonstrates Rapid Recent Spread of Copy
Number Variants
If chromosomes carrying gch1 CNP have been under strong
recent selection in Thailand, we would predict that genetic
diversity would be reduced and LD increased in the vicinity of gch1
on chr. 12. We measured length variation at 33 di-nucleotide
microsatellite markers (Table S1) distributed across chr. 12 in
parasites from the Thai-Burma border and Laos. These included a
cluster of 11 markers within 14 kb of gch1. Expected heterozygosity
(He) was high across chr. 12 in Laos (mean=0.85, s.d=0.08) and
at markers situated far from gch1 in Thai parasites. However, for
the 11 markers flanking gch1 variation was halved in Thai parasites
(He (6s.d.)=0.83 (60.07) in Laos vs He=0.4160.16 in Thailand)
(Figure 4) and variation was reduced in Thailand for 600–950 kb
(40–63 cM). These data are consistent with strong recent selection
acting on gch1 CNP. Comparison of this selective event with
selective sweeps around known drug resistance genes provides a
means to assess the strength of this selective event. We have
previously described patterns of microsatellite variation around
dhfr (chr. 4), the chloroquine resistance transporter (pfcrt (chr. 7)
using parasites collected from the same clinic [27]. We observed
significant reduction in variation for 98–137 kb (6–8 cM) around
dhfr, and for 195–268 kb (11–16 cM) around pfcrt. The window of
reduced variation is considerably larger around gch1, emphasizing
that selection on this locus was strong and recent. Examination of
extended haplotype homozygosity (EHH) also reveal striking
differences in LD between parasites from Thailand and Laos. In
Laos, haplotype blocks are short and EHH decays to ,0.02 within
3 kb on either side of gch1. In contrast, haplotype blocks extend
largely unbroken for 63 kb (4 cM) around gch1 in Thai parasites
with multiple copies of each of the three predominant amplicon
types bearing gch1. These data are consistent with rapid recent
spread of this CNP in Thailand (Figure 5).
Parallel Evolution of Structural Changes
We used the amplicon sizes and microsatellite haplotypes in
markers flanking gch1 to infer evolutionary origins of these gene
amplification events. Amplification of gch1 CNP has occurred at
least three times in Thailand. The 2.2 kb, 8.7 kb, and .11 kb
amplicon share identical or similar backgrounds, suggesting that
they share a common origin. We counted the mean proportion of
shared alleles between all pairwise combinations of parasites
carrying the 2.2 kb, 8.7 kb, and .11 kb amplicon for the 10
markers (12_970980–12_984557, Table S1) immediately flanking
gch1. 94.6–98.1% of alleles were shared between chromosomes
bearing these three amplicon types (Table 1). In contrast, the
markers flanking the 1.7 and 7.3 kb amplicons were divergent
from one another (42.0% shared alleles) and from the 2.2 and 8.7
and .11 kb amplicons (33.8–38.0% alleles shared). The simplest
explanation is that the 2.2 kb, 8.7 kb, and .11 kb amplicon share
the same origin, and that the 1.7 kb and 7.3 kb amplicons have
evolved independently. The observation that three amplicons
share the same flanking markers suggests that initially large
amplicons have been progressively reduced in size. Such amplicon
size reduction has been observed previously in E. coli [46]. In this
case, deletion of genes from large amplicons results in increased
growth rates and higher fitness. We expect that similar deleterious
fitness effects of large amplicons may lead to progressive reduction
in amplicon size in this system. Interestingly, chr. 12 bearing a
Figure 4. Genetic Diversity on chr. 12 in Thailand and Laos. Expected Heterozygosity plotted across chr. 12 in Thailand and Laos. The red
arrow marks the position of gch1. Markers are ordered on the x-axis which is not shown to scale.
doi:10.1371/journal.pgen.1000243.g004
Adaptive Copy Number Evolution in Plasmodium
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compared with single copy chromosomes from Laos. Furthermore,
haplotypes surrounding gch1 on single copy chromosomes are
similar to those seen in chromosomes bearing the 2.2 kb, 8.7 kb,
and .11 kb amplicons (Figure 5b). These observations suggest
that chromosomes carrying multiple copies of gch1 frequently
revert to single copy status. Reversion is predicted to be common
in the evolution of tandem amplifications [10] and contrasts with
SNPs where reversion is rare. Importantly, such reversion events
will limit the power of within-population long range haplotype
tests [36] to detect evidence for selection and will reduce LD
between CNP and flanking SNPs reducing the power of SNP
based genome wide association studies [1].
In the previous paragraph we argued that three of the five
amplicons have a common origin and reversion to single copy
status is frequent. However we cannot prove this scenario with the
current data and less parsimonious alternative evolutionary
scenarios are possible. For example, one haplotype could have
spread to high frequency prior to copy number amplification. The
three different amplicon types may have then evolved indepen-
dently on the same genetic background.
We have assumed so far that CNP itself is adaptive. However, it
is conceivable that CNP is linked to SNPs in gch1, which are the
true target of selection. We therefore sequenced 48 gch1 alleles.
These sequences (940 bp) were from 24 Thai samples, represent-
ing all five amplicon types as well as single copy gch1, and from 24
single copy gch1 alleles from Laos. Sequence polymorphism can be
difficult to detect in samples with high gch1 copy number.
However, of 16 samples with multiple copies of gch1 sequenced
only 3 carried .4 copies, so we do not believe our ability to detect
sequence variants was severely impaired. We found just one non
synonymous SNP (GRT, M169I) in one each of the Thai and Lao
samples, demonstrating low levels of nucleotide variation in this
gene. This sequence homogeneity supports the argument that
copy number, rather than associated coding SNPs, are targeted by
selection.
LD between Physically Unlinked Genes in the Folate
Pathway
The demonstration that a derived gch1 CNP has rapidly spread
to high frequency within Thai parasite populations, but not in
neighboring populations from Laos, provides strong evidence that
gch1 is adaptive, but provides few clues about the nature of the
selection involved. We reasoned that if gch1 CNP is involved
directly or indirectly in resistance to antifolate drugs, we might
expect to see genetic evidence for interactions with genes involved
in resistance downstream in the folate biosynthesis pathway. We
therefore examined associations between gch1 copy number and
known mutations that underlie antifolate resistance in dhfr (chr. 4)
and dhps (chr. 8). In Thailand parasites bearing dhfr-164L carried
significantly higher copy number of gch1 (t=24.313,
p=0.000026) than those bearing dhfr-164I (Figure 6a). More
marginal associations were also observed for dhfr-N51I
(t=21.964, p=0.051) and two sites (A436S and A581G) in dhps
(t=22.184, p=0.033) in perfect LD. To empirically test the
significance of the dhfr-164L result we compared associations
between gch1 copy number and 55 sSNPs with minor allele
frequency .5% in Thailand. The dhfr-164L association was the
Figure 5. Haplotype structure and LD decay around gch1. (a)
Plots of EHH for markers flanking gch1 from Thailand and Laos. In
Thailand, EHH is plotted for the three predominant amplicon types (2.2,
7.3 and 8.7 kb). EHH for chromosomes with single copies of gch1 from
both countries is shown for comparison. (b) Visual representation of LD.
Microsatellite data was reduced to binary form by coloring the
predominant allele in black and all other alleles in white. The 33 loci
typed are arranged in order across the chromosome, while samples are
arranged in rows. The country of origin of each sample is shown on the
left, while the amplicon type (Figure 2) is shown on the right.
doi:10.1371/journal.pgen.1000243.g005
Table 1. Proportion of alleles shared at microsatellite loci
flanking gch1 on chromosomes bearing different amplicon
types.
Single 1.7 kb 2.2 kb 7.3 kb 8.7 kb .11 kb
Single 0.537
1.7 kb 0.438 0.419
2.2 kb 0.734 0.387 0.897
7.3 kb 0.467 0.417 0.380 0.793
8.7 kb 0.699 0.367 0.946 0.345 0.963
.11 kb 0.689 0.367 0.947 0.339 0.981 1.000
We compared haplotypes at 10 microsatellite markers in a 14 kb region
containing gch1. Comparisons showing .90% similarity are shown in bold.
Chromosomes carrying the 2.2, 8.7 and .11 kb amplicon show identical or near
identical backgrounds suggesting they have a common origin. The proportion
of shared alleles observed between chromosomes carrying the same amplicon
type is shown on the diagonal in italics.
doi:10.1371/journal.pgen.1000243.t001
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multiple tests, arguing that this association cannot be explained by
population structure (Figure 6b). These results reveal the genetic
signature of functional interaction (epistasis for fitness) between
two physically unlinked genes in the same biochemical pathway,
providing strong evidence that gch1 CNP results either directly or
indirectly from antifolate selection.
In Thailand, antifolate drugs were abandoned as first line
therapy ,25 years ago, and are rarely used in neighboring Burma
[24], although low levels of indirect selection may result from use
of a related antifolate drug (Cotrimoxazole) used for treatment of
bacterial infections [47]. Because reassortment and recombination
during meiosis breaks down LD between genes, there must be
strong selection favoring association of gch1 CNP and dhfr-164L in
the absence of sustained antifolate selection. Hence, these data are
consistent with the hypothesis that gch1 CNP compensates for
reduced efficiency of dhfr-164L [12]. Selection could increase gch1
copy number within infections carrying dhfr-164L. Alternatively,
recombinants bearing dhfr-164L/wild-type gch1 or dhfr-164I/gch1
CNP may suffer fitness costs and fail to establish infections.
Compensatory evolution involving amplification of initiator tRNA
genes has previously been observed during laboratory evolution of
Salmonella. In this case, amplification mitigates fitness costs of point
mutations conferring resistance to deformylase inhibitors [48].
The associations observed between dhfr-164L and elevated gch1
copy number in Plasmodium are all the more remarkable, because
they are maintained in the face of recombination. The strength of
selection required to maintain multilocus allelic combinations
depends on levels of inbreeding, because this determines the rate
at which recombination breaks up such combinations. In the Thai
population ,40% of infections contained multiple parasite clones,
consistent with high levels of inbreeding (f=0.6–0.90 [31].
Therefore, selection must be sufficiently strong to overcome
breakdown of favorable allele combinations in 10–40% of the
parasite population during each generation. LD is rarely observed
between unlinked genes in recombining organisms: it is possible in
this situation because outcrossing is rare and selection is strong.
Gch1 Gene Dosage Affects Gene Expression
The data presented provides strong evidence that gch1 CNP is
adaptive and associated with antifolate drug selection. An
important assumption made is that gene dosage is reflected in
increased transcription of amplified genes. To test this assumption
directly, we grew six parasites in the laboratory that vary in gch1
copy number, and harvested mRNA at 4 different time periods in
the asexual cycle. We observe strong correlations between copy
number and expression in all stages of the cycle validating this
assumption (Figure 7). Hence, increased expression of gch1 has the
potential to increase flux in the folate pathway. However, detailed
Figure 6. The dhfr-164L resistance mutation is associated with
gch1 CNP in Thailand. (a) Thai parasites were ranked by gch1 CNP.
Error bars show 95% CI around copy number estimates. Open black
circles or closed red circles indicate isolates carrying 164I or 164L at dhfr.
(b) Association between 55 polymorphic sSNPs and gch1 CNP. Raw
p-values from t-tests of log transformed copy number estimates are
plotted; very similar p-values were obtained from non-parametic Mann-
Whitney U-tests using untransformed copy number estimates. Dotted
horizontal lines show thresholds for significance following Bonferroni
correction for multiple testing. The bars show the strength of
associations between gch1 CNP and dhfr-I164L (solid red), between
polymorphic SNPs in dhfr (N51I) and dhps (S436A, K540E, A581G) (open
red bars), and between 55 sSNPs (black). There was only one SNP
(MAL04-469608) other than dhfr-164L that crossed the Bonferroni-
corrected threshold of p,0.05.
doi:10.1371/journal.pgen.1000243.g006
Figure 7. Correlation between gch1 CNP and expression for 6
parasite isolates. We measured gene expression and copy number at
4 different time points in the asexual cycle. Error bars indicate 95% CI
for estimates of both CNP and expression. Details of the real-time PCR
assay are shown in Table S2. Linear regression summary statistics (slope,
r
2, F, p-value) for the four time points were as follows: 0–6 hrs: 0.63,
0.71, 10.36, 0.032, 8–14 hrs: 0.649, 0.87, 25.89, 0.007, 24–30 hrs: 0.419,
0.621, 6.54, 0.063, 32–40 hrs: 0.46, 0.85, 22.01, 0.009).
doi:10.1371/journal.pgen.1000243.g007
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fully understand the impact of copy number of the dynamics of
folate biosynthesis in Plasmodium.
Complexity of Antifolate Evolution
The evolution of resistance to antifolate drugs has been assumed to
have a simple genetic basis, because a small number of point
mutations are involved and resistance can be selected in the
laboratory [49]. However, molecular genetic data from regions
flankingdhfr demonstrate surprisinglyfew origins and intercontinental
movement of high level resistance alleles [31,50]. Furthermore, while
parasites carrying the three mutations in dhfr are now widespread in
Africa, the I164L mutation, which signals the end of the useful life of
pyrimethamine-sulfadoxine treatment, has not spread on this
continent. Our results demonstrate that adaptation to antifolate
selection is more complex than has previously been recognized, with
involvement of three different components of the folate pathway (dhfr,
dhps and gch1). This result parallels recent identification of multiple
selected genes within metabolic pathways involved in skin pigmen-
tation, hair and exocrine development, and lassa fever susceptibility
in humans [51]. Hence, involvement of gch1 CNP is consistent with a
multilocus model for antifolate resistance evolution.
The Nature of Selection on gch1 CNP
The precise manner in which antifolate treatment selects for
increased copy number at gch1 remains unclear. There are two
possible explanations. First, gch1 amplification may be directly
selected by antifolate treatment. In this case parasites bearing
multiple copies of gch1 might be expected to show higher levels of
resistance than those carrying a single copy. We have not tested this
hypothesis, which we believe is unlikely. If this were the case then we
would not expect to see associations with dhfr in the absence of drug
selection. Second, as envisaged by Kidgell et al [12], gch1
amplification may compensate for reduced efficacy of dhfr and/or
dhps enzymes bearing resistance mutations downstream in the
biosynthesis pathway. Kidgell et al [12] favored compensation for
fitness effects of mutations in dhps. However, the associations we
observe between dhfr-164 and gch1 CNP argues strongly for
involvement with dhfr. Ultimately, manipulation of gch1 copy number
will be required to determine the phenotypic impact of gene
amplification. We caution that the effects of copy number
manipulation may be strongly dependent on parasite genetic
background. Hence transfection experiments designed to better
understand gch1 amplification will need to carefully consider
background mutations present in dhfr and dhps and measure fitness
in both the presence and absence of drug treatment.
Screening for CNP Provides a Fast Track to Locating
Genes that Underlie Adaptation
There are now six genes known that are involved in adaptation to
drug treatment in P. falciparum. These include pfcrt (Chloroquine/
quinine resistance), dhfr (pyrimethamine resistance), dhps (sulfadoxine
resistance), pfmdr1 (resistance to multiple drugs), mtDNA cytochrome
b (atovaquone resistance) [52] and gch1. CNP is involved in two
(pfmdr1 and gch1) of these six genes (33%). We suggest that high
frequency CNPs will be enriched for genes involved in adaptation, as
is the case for high frequency derived SNPs [51]. Such CNPs can
easily be located by cGH surveys of different parasite populations.
The observation that CNP is involved in resistance to drug treatment
in otherpathogenicprotozoa, bacteria, and cancers[53–55], provides
further empirical evidence that CNP may be a common evolutionary
response to strong selection. There is currently a strong community-
wide effort to generate a high density SNP map for P. falciparum to
help identify the genetic determinants of drug resistance and
virulence by genome wide association [17]. Such SNP based screens
may succeed in detecting functional CNPs. However, SNP maps in
humans tend to be sparse in regions of CNP and LD between CNP
and flanking SNPs is often minimal, so it is much better to determine
CNP directly [1,56]. Fortunately, this is now relatively easy using
either microarray or ‘‘next generation’’ sequence technology. We
suggest that the combination of direct assessment of CNP with dense
genome-wide SNP data [6] is likely to provide a particularly powerful
approach to understand the genetic determinants of adaptation to
drug treatment and other selective forces in malaria parasites and
other pathogens.
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